Table of Contents

October 1992; 41 (10)

Select this article
- S Misler,
- D W Barnett,
- K D Gillis,
- and D M Pressel
Electrophysiology of stimulus-secretion coupling in human beta-cells.
Diabetes October 1992 41:1221-1228; doi:10.2337/diabetes.41.10.1221
- Abstract
Select this article
- D H Wasserman,
- T Mohr,
- P Kelly,
- D B Lacy,
- and D Bracy
Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.
Diabetes October 1992 41:1229-1238; doi:10.2337/diabetes.41.10.1229
- Abstract
Select this article
- R Trevisan,
- L K Li,
- J Messent,
- T Tariq,
- K Earle,
- J D Walker,
- and G Viberti
Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy.
Diabetes October 1992 41:1239-1246; doi:10.2337/diabetes.41.10.1239
- Abstract
Select this article
- M J Pagliassotti,
- M C Moore,
- D W Neal,
- and A D Cherrington
Insulin is required for the liver to respond to intraportal glucose delivery in the conscious dog.
Diabetes October 1992 41:1247-1256; doi:10.2337/diabetes.41.10.1247
- Abstract
Select this article
- A Dunaif,
- K R Segal,
- D R Shelley,
- G Green,
- A Dobrjansky,
- and T Licholai
Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
Diabetes October 1992 41:1257-1266; doi:10.2337/diabetes.41.10.1257
- Abstract
Select this article
- S M Haffner,
- P A Morales,
- M P Stern,
- and M K Gruber
Lp(a) concentrations in NIDDM.
Diabetes October 1992 41:1267-1272; doi:10.2337/diabetes.41.10.1267
- Abstract
Select this article
- S Bertrand,
- M De Paepe,
- C Vigeant,
- and J F Yale
Prevention of adoptive transfer in BB rats by prophylactic insulin treatment.
Diabetes October 1992 41:1273-1277; doi:10.2337/diabetes.41.10.1273
- Abstract
Select this article
- A Garg,
- S M Grundy,
- and R H Unger
Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM.
Diabetes October 1992 41:1278-1285; doi:10.2337/diabetes.41.10.1278
- Abstract
Select this article
- D R Sell,
- A Lapolla,
- P Odetti,
- J Fogarty,
- and V M Monnier
Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Diabetes October 1992 41:1286-1292; doi:10.2337/diabetes.41.10.1286
- Abstract
Select this article
- B J Goldstein and
- A L Dudley
Heterogeneity of messenger RNA that encodes the rat insulin receptor is limited to the domain of exon 11. Analysis by RNA heteroduplex mapping, amplification of cDNA, and in vitro translation.
Diabetes October 1992 41:1293-1300; doi:10.2337/diabetes.41.10.1293
- Abstract
Select this article
- R L Klein,
- H J Wohltmann,
- and M F Lopes-Virella
Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages.
Diabetes October 1992 41:1301-1307; doi:10.2337/diabetes.41.10.1301
- Abstract
Select this article
- C C Connolly,
- B A Adkins-Marshall,
- D W Neal,
- W Pugh,
- J B Jaspan,
- and A D Cherrington
Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.
Diabetes October 1992 41:1308-1319; doi:10.2337/diabetes.41.10.1308
- Abstract
Select this article
- C Chen,
- B Thorens,
- S Bonner-Weir,
- G C Weir,
- and J L Leahy
Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
Diabetes October 1992 41:1320-1327; doi:10.2337/diabetes.41.10.1320
- Abstract
Select this article
- G R Sutherland,
- J Peeling,
- E Sutherland,
- R Tyson,
- F Dai,
- P Kozlowski,
- and J K Saunders
Forebrain ischemia in diabetic and nondiabetic BB rats studied with 31P magnetic resonance spectroscopy.
Diabetes October 1992 41:1328-1334; doi:10.2337/diabetes.41.10.1328
- Abstract
Select this article
- M R Davis,
- M Mellman,
- and H Shamoon
Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
Diabetes October 1992 41:1335-1340; doi:10.2337/diabetes.41.10.1335
- Abstract
Select this article
- M Sidhu,
- D Crook,
- I F Godsland,
- C Walton,
- V Wynn,
- and M F Oliver
Inverse relationship between serum Lp(a) levels and first-phase insulin secretion.
Diabetes October 1992 41:1341-1345; doi:10.2337/diabetes.41.10.1341
- Abstract
Select this article
- J D Blackman,
- K S Polonsky,
- J B Jaspan,
- J Sturis,
- E Van Cauter,
- and J R Thistlethwaite
Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.
Diabetes October 1992 41:1346-1354; doi:10.2337/diabetes.41.10.1346
- Abstract
Select this article
- A E Karlsen,
- W A Hagopian,
- J S Petersen,
- E Boel,
- T Dyrberg,
- C E Grubin,
- B K Michelsen,
- O D Madsen,
- and A Lernmark
Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies.
Diabetes October 1992 41:1355-1359; doi:10.2337/diabetes.41.10.1355
- Abstract
Select this article
- P R Shepherd,
- E M Gibbs,
- C Wesslau,
- G W Gould,
- and B B Kahn
Human small intestine facilitative fructose/glucose transporter (GLUT5) is also present in insulin-responsive tissues and brain. Investigation of biochemical characteristics and translocation.
Diabetes October 1992 41:1360-1365; doi:10.2337/diabetes.41.10.1360
- Abstract

Current Issue

February 2012, 61 (2)

Print ISSN: 0012-1797
Online ISSN: 1939-327X

Diabetes

Electrophysiology of stimulus-secretion coupling in human beta-cells.

Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.

Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy.

Insulin is required for the liver to respond to intraportal glucose delivery in the conscious dog.

Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.

Lp(a) concentrations in NIDDM.

Prevention of adoptive transfer in BB rats by prophylactic insulin treatment.

Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM.

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.

Heterogeneity of messenger RNA that encodes the rat insulin receptor is limited to the domain of exon 11. Analysis by RNA heteroduplex mapping, amplification of cDNA, and in vitro translation.

Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages.

Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog.

Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.

Forebrain ischemia in diabetic and nondiabetic BB rats studied with 31P magnetic resonance spectroscopy.

Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.

Inverse relationship between serum Lp(a) levels and first-phase insulin secretion.

Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.

Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies.

Human small intestine facilitative fructose/glucose transporter (GLUT5) is also present in insulin-responsive tissues and brain. Investigation of biochemical characteristics and translocation.

This Issue

Current Issue